Dagens industri: Enzymatica (ENZY) Shares Dip Slightly to 2.36 SEK

On September 26, 2025, Enzymatica (ENZY), a healthcare company listed on the First North exchange, experienced a share price decline of 0.84%, closing at 2.36 SEK. Trading for the day ranged from a high of 2.45 SEK to the closing low of 2.36 SEK, with a total volume of 49,361 shares traded. Based on 242,735,108 outstanding shares, Enzymatica's market capitalization at the closing price was 573 million SEK. This data, sourced from Millistream and reported by Dagens industri, is subject to a 15-minute delay for non-subscribers. Financial analysis reveals a price-to-sales (P/S) ratio of 12.57. The company's price-to-earnings (P/E) ratio is negative at -10.95, reflecting an earnings per share (EPS) of -0.28 SEK and indicating unprofitability for the period. The price-to-equity ratio was calculated at 3.25. Further financial metrics include an equity per share of 0.73 SEK and revenue per share of 0.19 SEK. The company did not issue dividends, resulting in a dividend per share and a direct dividend yield of 0.00.